Highlights Myomo, Inc.

Equities

MYO

US62857J2015

Market Closed - Nyse Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
3.41 ^USD	-1.73%		-10.97%	-31.94%

May. 23	Lake Street Starts Myomo With Buy Rating, $7 Price Target	MT
May. 08	Transcript : Myomo, Inc., Q1 2024 Earnings Call, May 08, 2024

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Myomo, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024	May. 08	CI
Myomo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Myomo Receives Reimbursements For MyoPros from CMS	May. 06	MT
Earnings Flash (MYO) MYOMO Reports Q4 Revenue $4.8M, vs. Street Est of $4.8M	Mar. 07	MT
Myomo, Inc. Provides Earnings Guidance for the First Quarter of 2024	Mar. 07	CI
Myomo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
Myomo, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 07	CI
Myomo, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023	Jan. 17	CI
Myomo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
Earnings Flash (MYO) MYOMO Posts Q3 Revenue $5.1M, vs. Street Est of $4.2M	Nov. 07	MT
Myomo, Inc. Provides Revenue Guidance for the Full Year of 2023	Nov. 07	CI
Myomo, Inc. Announces CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro for Review at the Upcoming HCPCS Public Meeting	Nov. 06	CI
Earnings Flash (MYO) MYOMO Posts Q2 Revenue $6M, vs. Street Est of $5.6M	23-08-09	MT
Myomo, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Centers for Medicare and Medicaid Services Accepts Myomo, Inc.'s Application to Classify the MyoPro as A Brace	23-07-03	CI
Earnings Flash (MYO) MYOMO Posts Q1 Revenue $3.45M, vs. Street Est of $3.34M	23-05-10	MT
Myomo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Myomo, Inc. Reiterates Revenue Guidance for the Second Quarter of 2023	23-05-10	CI
Myomo, Inc. Provides Revenue Guidance for the Second Quarter of 2023	23-05-10	CI
Myomo, Inc. Receives Technology License Fee Payment from China Joint Venture Company	23-04-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Myomo, Inc.

Equities

MYO

US62857J2015

Highlights

Filters